Mitochondrial DNA Sample Clauses

Mitochondrial DNA. An approximately 450 base pair (bp) portion of the mitochondrial control region (D loop) was amplified from the previously isolated genomic DNA using primers H16498 (5’-CCTGAACTAGGAACCAGATG-3’) and L15774 (5’- GTAAAACGACGGCCAGTACATGAATTGGAGGACAACCAGT-3’) of Xxxxxxx and Xxxxxx (1991). Polymerase chain reaction (PCR) amplifications were performed in 50 μl volumes containing 500 ng of DNA, 5 μl of 10X Buffer, 4 μl of MgCl2, 2 μl of 10 mM dNTPs, 2.5 μl of each 20 μM primer, and 1.5 U Taq polymerase. Thermal profile conditions consisted of 1 cycle of initial denaturation at 95°C for 10 minutes; 30 cycles of 94°C denaturation for 1 minute, 55°C annealing for 1 minute, and 72°C extension for 1 minute; and a final extension of 72°C for 30 minutes. PCR products were purified with Performa® spin columns (Edge Biosystems, Gaithersburg, Maryland). After cycle- sequencing and additional purification, samples were run on an ABI PRISM® 3100 Genetic Analyzer using BigDye chain terminators (Applied Biosystems, Foster City, California). Sequencher 3.0 software (Gene Codes, Ann Arbor, Michigan) was used to align fragments and to proof nucleotide sequences, and CLUSTAL X (Xxxxxxxx et al. 1997) was used for multiple sequence alignments. Unique haplotypes were determined using Collapse 1.2 (available from xxxx://xxxxxx.xxxxx.xx), and a minimum spanning network of haplotypes was constructed using TCS 1.21 (Xxxxxxx et al. 2000). Haplotype diversity and nucleotide diversity indices were calculated from the data using Arlequin 3.11 software (Excoffier et al. 2005). To test for isolation by distance, a Mantel test was performed with 1,000 permutations using the genetic and geographic distances calculated between all samples in Microsoft Excel with PopTools version 2.7 (Hood 2006).
AutoNDA by SimpleDocs
Mitochondrial DNA. Sixteen unique mitochondrial haplotypes were identified from the 182 raccoons sampled in northeastern Ohio (Table 2.4). Table 2.4 Definition of 16 unique mitochondrial haplotypes found in 182 raccoons in northeastern Ohio. Polymorphic sites contributing to haplotype definitions are shown with individual site numbers listed vertically. 000122222222222222222222222222222222222222233333333333444 669305666666677777777778888888888999999999903334778999355 127502345678901234567890123456789012345678997892120128727 XX0 XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX-XXXXXXXXXXXX XX0 G OH3 ................................................G G OH4 ...A.............................................C...T..G OH5 ...........................................C G OH6 GAC..G..........................................X.X.XX..G OH7 GA...G. G.T.ATG.G OH8 GA...G.................C......................AA..TAAT..G OH9gap GA...G- ....G....X.XX..G OH10 GA...G..........................................G.T..T..G OH11 GA..TG. X.XX.XX OH12 GA...G..........................................X.X.XX..G OH13 GA...G............................................X.XX..G OH13gap GA...G- .........X.XX..G OH14gap GA...G- ...T...X.X.XX..G OH15gap GA...G- A.T...X.X.XX..G No double peaks which might be indicative of nuclear copies of mitochondrial DNA (numts) were observed. Of 460 aligned sites, 57 sites were variable. A single nucleotide insertion was found in 2 haplotypes. In addition, 3 haplotypes possessed a 35 bp deletion and another haplotype contained a 36 bp deletion. For the purpose of nucleotide diversity calculations and subsequent analyses, the 35 bp gap was treated as a single evolutionary event. The most common haplotype in the region, OH12, was identified as the probable ancestral haplotype (Figure 2.4). OH13gap most likely gave rise to the other haplotypes containing insertion/deletion events. Spatial structuring within the area was observed for some of the less frequently sampled mitochondrial haplotypes whereas a large amount of overlap was observed in the distributions of those that were encountered more frequently. Haplotype diversity was moderately high (0.8238 ± 0.0159) whereas nucleotide diversity was relatively low (0.0091 ± 0.0051) suggesting that most of the haplotypes in the region differed only by a few nucleotides (Figure 2.4). If multiple populations had been present, one might have expected to observe spatially segregated, distinct haplotype lineages with varying haplotype frequencie...
Mitochondrial DNA. Xxxxxxxx xxxx was generated for an approximately 450 base pair (bp) portion of the mitochondrial control region (D loop) from genomic DNA using the primers H16498 and L15774 (Xxxxxxx and Xxxxxx 1991; see also Chapter 2). Polymerase chain reaction (PCR) amplifications were performed in 50 μl volumes with 500 ng of DNA, 5 μl of 10X Buffer, 4 μl of MgCl2, 2 μl of 10 mM dNTPs, 2.5 μl of each 20 μM primer, and 1.5 U Taq polymerase. Thermal profile conditions consisted of 1 cycle of initial denaturation at 95°C for 10 minutes; 30 cycles of 94°C denaturation for 1 minute, 55°C annealing for 1 minute, and 72°C extension for 1 minute; and a final extension of 72°C for 30 minutes. After cycle-sequencing reactions and additional purification, samples were run on an ABI PRISM® 3100 Genetic Analyzer using BigDye chain terminators (Applied Biosystems, Foster City, California). For analyses based on mitochondrial DNA sequencing, nucleotide fragments were aligned and proofed with Sequencher 3.0 software (Gene Codes, Ann Arbor, Michigan), and a multiple sequence alignment was generated using CLUSTAL X (Xxxxxxxx et al.
Mitochondrial DNA. Ninety-two distinct mitochondrial haplotypes were identified (Figure 3.5). No double peaks, which might be indicative of nuclear copies of DNA (numts), were observed. Of 440 aligned nucleotides, 71 sites were polymorphic. Haplotype diversity was relatively high (0.8692 ± 0.0304) whereas nucleotide diversity was low (0.0139 ± 0.0073; Table 3.4). The majority of haplotypes differed by a small number of substitutions, although a 35 bp deletion was present in 4 separate haplotypes found in the northeastern part of the study area. Furthermore, one haplotype not containing the deletion event contained an additional 36 bp insertion. For all population genetic analyses, these insertion/deletion events were represented as single evolutionary events. Three main haplotype groups were identified (Figure 3.5), roughly corresponding to the populations described based on the microsatellite results: one consisting of samples from all localities except Florida (I); another group restricted to Ohio, Tennessee, Kentucky, and West Virginia (II); and a final group containing samples from Florida, Georgia, Alabama, and Tennessee (III). All 3 haplotype groups were represented in Tennessee. Most haplotypes were limited in range, although a single nearly cosmopolitan haplotype belonging to haplotype group I was found in every location sampled with the exception of Florida. This particular haplotype was widely distributed and occurred at the highest overall frequency (Figure 3.5), resulting in its identification as the likely ancestral haplotype. Figure 3.5 Distribution of the 3 haplotype groups—states with a single haplotype group are shown with vertical lines; states where 2 haplotype groups occur are shown with dots; all 3 haplotype groups are found in Tennessee, shown in purple. Node size corresponds to relative haplotype frequency. Unsampled haplotypes are shown as small, open circles. Branch lengths correspond to the number of mutational steps between haplotypes. The 4 haplotypes in group I containing a 35 bp deletion event are indicated via a light xxxx line with a break. Table 3.4 Haplotype and nucleotide diversity indices and neutrality tests. Sample size (n), haplotype diversity (Ĥ), and nucleotide diversity (π). For Chakraborty’s test, the number indicates number of observed alleles (for this test, p < 0.02 is equivalent to p < Population 1 2 3 Avg N 218 228 179 208 Ĥ 0.8437±0.0146 0.9633±0.0077 0.8007±0.0689 0.8692±0.0304 π 0.0183±0.0094 0.0177±0.0091 0.0057±0.0035 0.01...

Related to Mitochondrial DNA

  • Hepatitis B Vaccine Where the Hospital identifies high risk areas where employees are exposed to Hepatitis B, the Hospital will provide, at no cost to the employees, a Hepatitis B vaccine.

  • Influenza Vaccine Upon recommendation of the Medical Officer of Health, all employees shall be required, on an annual basis to be vaccinated and or to take antiviral medication for influenza. If the costs of such medication are not covered by some other sources, the Employer will pay the cost for such medication. If the employee fails to take the required medication, she may be placed on an unpaid leave of absence during any influenza outbreak in the home until such time as the employee has been cleared by the public health or the Employer to return to the work environment. The only exception to this would be employees for whom taking the medication will result in the employee being physically ill to the extent that she cannot attend work. Upon written direction from the employee’s physician of such medical condition in consultation with the Employer’s physician, (if requested), the employee will be permitted to access their sick bank, if any, during any outbreak period. If there is a dispute between the physicians, the employee will be placed on unpaid leave. If the employee gets sick as a reaction to the drug and applies for WSIB the Employer will not oppose the application. If an employee is pregnant and her physician believes the pregnancy could be in jeopardy as a result of the influenza inoculation and/or the antiviral medication she shall be eligible for sick leave in circumstances where she is not allowed to attend at work as a result of an outbreak. This clause shall be interpreted in a manner consistent with the Ontario Human Rights Code.

  • Human Leukocyte Antigen Testing This plan covers human leukocyte antigen testing for A, B, and DR antigens once per member per lifetime to establish a member’s bone marrow transplantation donor suitability in accordance with R.I. General Law §27-20-36. The testing must be performed in a facility that is: • accredited by the American Association of Blood Banks or its successors; and • licensed under the Clinical Laboratory Improvement Act as it may be amended from time to time. At the time of testing, the person being tested must complete and sign an informed consent form that also authorizes the results of the test to be used for participation in the National Marrow Donor program.

  • Vlastnictví Zdravotnické zařízení si ponechá a bude uchovávat Zdravotní záznamy. Zdravotnické zařízení a Zkoušející převedou na Zadavatele veškerá svá práva, nároky a tituly, včetně práv duševního vlastnictví k Důvěrným informacím (ve smyslu níže uvedeném) a k jakýmkoli jiným Studijním datům a údajům.

  • Musculoskeletal Injury Prevention and Control The hospital in consultation with the Joint Health and Safety Committee (JHSC) shall develop, establish and put into effect, musculoskeletal prevention and control measures, procedures, practices and training for the health and safety of employees.

  • Prosthodontics We Cover prosthodontic services as follows:

  • PROGENY Unmodified descendant from the MATERIAL, such as virus from virus, cell from cell, or organism from organism.

  • Diagnostic procedures to aid the Provider in determining required dental treatment.

  • SMT XXXXXX XXXXXXXX, daughter of Sri Pawan Kumar Xxxxxxxx, by occupation – Housewife, (4) XXXXXXX XXXXXXXX, daughter of Sri Pawan Kumar Xxxxxxxx, by occupation – Others , all are by faith – Hindu, by Nationality – Indian, all are residing at Radhanagar Road, P.O. Burnpur, P.S. – Haripur, District – Burdwan, presently residing at Kamalgazi, P.S. Sonarpur, Kolkata – 700103, SRI PAWAN KUMAR XXXXXXXX, SMT. XXXXXXX XXXX XXXXXXXX, SMT. XXXXXX XXXXXXXX and XXXXXXX XXXXXXXX all are being represented by their Constituted Attorney, “M/S. RAJWADA GROUP” (PAN- XXXXX0000X), a Partnership Firm having its registered office at 00, Xxxxxxxx Xxxxxx Xxxx, Xxxxxxxxxxxx, Xxxxx, P.S. Sonarpur, Kolkata -700 084, duly represented by its authorised signatory SRI XXXXXX XXXXXXX (PAN- XXXXX0000X), son of Late Xxxxxxxx Xxxxx Agarwal, by faith- Hindu, by Nationality- Indian, by occupation-Business, residing at 00, Xxxxxxxx Xxxxxx Xxxx, Xxxxxxxxxxxx, Xxxxx, Police Station Sonarpur, Kolkata- 700 084, and also residing at “Narendra Bhawan”, Kamalgazi, Post Office- Narendrapur, Police Xxxxxxx Xxxxxxxx, Xxxx Xxxxx 00 Xxxxxxxx, Xxxxxxx – 700103, by virtue of a Development Power of Attorney which was duly registered on 25th March, 2015, before the office of the D.S.R. IV, South 24 Parganas at Alipore which is recorded in its Book Xx. 0, XX Xxxxxx Xx. 0, pages from 5832 to 5845, Being no. 02580 for the year 2015, hereinafter called and referred to as the “OWNERS/VENDORS” (which term or expression shall unless excluded by or repugnant to the context be deemed to mean and include their heirs, executors, administrators, legal representatives and assigns) of the FIRST PART. “M/S. RAJWADA GROUP” (PAN- XXXXX0000X), a Partnership firm having its registered office at 00, Xxxxxxxx Xxxxxx Xxxx, Xxxxxxxxxxxx, Post Office- Garia, P.S. Sonarpur, Kolkata – 700084, duly represented by its represented by one of its Partners and Constituted Attorney by virtue of registered General Power of Attorney dated 29.01.2015, registered at the Office of the Additional District Sub Registrar at Garia and recorded in Book No. IV, CD. Volume No. I, Pages from 207 to 216, Being No. 00021 for the year 2015 namely, SRI XXXXXX XXXXXXX, son of Late Xxxxxxxx Xxxxx Agarwal, by occupation- Business, by religion- Hindu, by- Nationality- Indian, residing at 00, Xxxxxxxx Xxxxxx Xxxx, Xxxxxxxxxxxx, Xxxxx, Post Office-Garia, Police Station-Sonarpur, Kolkata-700 084, hereinafter collectively referred to as the ‘DEVELOPER’ (which expression shall unless excluded by or repugnant to the context be deemed to mean and include his heirs, executors, administrators, legal representatives, and assigns) of the SECOND PART. ………, by religion - ……….., by Nationality- ……….., by occupation- ……………, residing at …………………., hereinafter called and referred to as the “PURCHASER” (which term or expression shall unless excluded by or repugnant to the context be deemed to mean and include his/her/their heirs executors, administrators, legal representatives and assigns) of the THIRD PART.

  • Field The term “

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!